Search results for “Cyp3A4 Inducer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 157 patents, we discovered top 71 key players by total patent application. Boehringer Ingelheim International GmbH, Veloxis Pharmaceuticals, Inc., Merck Sharp & Dohme Corp. are dominant in this area. They take 15.92% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 9
Veloxis Pharmaceuticals, Inc.
New Jersey, United States
Patent: 9
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 7
Global Blood Therapeutics, Inc.
California, United States
Patent: 6
Merck & Co., Inc.
New Jersey, United States
Patent: 5
Kissei Pharmaceutical Co., Ltd.
Nagano-ken, Japan
Patent: 5
Neurocrine Biosciences, Inc.
California, United States
Patent: 5
Veloxis Pharmaceuticals A/S
Hovedstaden, Denmark
Patent: 5
Abbott Laboratories
Illinois, United States
Patent: 4
Xenogen Corp.
California, United States
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Global Blood Therapeutics, Inc., Medivation Prostate Therapeutics LLC, Astellas Pharma, Inc. take 43.48% of patent filing during this period.
Global Blood Therapeutics, Inc.
California, United States
Patent: 6
Medivation Prostate Therapeutics LLC
California, United States
Patent: 2
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 2
Odonate, Inc.
California, United States
Patent: 2
Bow River LLC
United States
Patent: 2
Jinhua Polytechnic
Zhejiang Sheng, China
Patent: 1
PTC Therapeutics, Inc.
New Jersey, United States
Patent: 1
Vanda Pharmaceuticals, Inc.
District of Columbia, United States
Patent: 1
Suzhou Doerdun Gene Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Dali University
Yunnan Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents in last 5 years, we discover 8 new entrants. Global Blood Therapeutics, Inc., Odonate, Inc., Medivation Prostate Therapeutics LLC are the most active new entrants in this area.
Global Blood Therapeutics, Inc.
California, United States
Patent: 6
Odonate, Inc.
California, United States
Patent: 2
Medivation Prostate Therapeutics LLC
California, United States
Patent: 2
Dali University
Yunnan Sheng, China
Patent: 1
Jinhua Polytechnic
Zhejiang Sheng, China
Patent: 1
Xenon Pharmaceuticals, Inc.
British Columbia, Canada
Patent: 1
Suzhou Doerdun Gene Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Dalian Medical University
Liaoning Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 77 patents, we discovered top 25 universities and scientific research institutions by total patent application. The University of Sydney, The Children's Hospital of Philadelphia, Duke University are dominant in this area. They take 49.35% of the total patent filing.
The University of Sydney
Australia
Patent: 28
The Children's Hospital of Philadelphia
Pennsylvania, United States
Patent: 3
Duke University
North Carolina, United States
Patent: 2
Université Catholique de Louvain
Vlaams-Brabant, Belgium
Patent: 2
University of Washington
Washington, United States
Patent: 1
McGill University
Ontario, Canada
Patent: 1
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 1
University of Saskatchewan
Saskatchewan, Canada
Patent: 1
Jilin University
Jilin Sheng, China
Patent: 1
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: